Friday, May 15, 2020

Unique MS Method Could Narrow Down Search for COVID-19 Drug Treatment

A team of biochemists and virologists at Goethe University and the Frankfurt University Hospital were able to observe how human cells change upon infection with SARS-CoV-2, the virus causing COVID-19 in people. The scientists tested a series of compounds in laboratory models and found some which slowed down or stopped virus reproduction. These results now enable the search for an active substance to be narrowed down to a small number of already approved drugs. (Nature DOI: 10.1038/s41586-020-2332-7). Based on these findings, a U.S.-based company reports that it is preparing clinical trials. A Canadian company is also starting a clinical study with a different substance. Laboratory Equipment 

No comments:

Post a Comment